Impact of molecular prognostic factors in advanced bladder cancer patients receiving chemotherapy
Rasha Mohamed Mostafa Haggag;
Abstract
Background: Bladder carcinoma is the foremost oncological problem in Egypt, being the most common malignant tumor among Egyptian males. Gemcitabine is an active agent in the treatment of bladder cancer. Prolonged infusion of gemcitabine and cisplatin is a
Other data
| Title | Impact of molecular prognostic factors in advanced bladder cancer patients receiving chemotherapy | Other Titles | تأثير العوامل الجزيئية المنذرة فى حالات سرطان المثانة المتقدم التى تتلقى العلاج الكيميائي | Authors | Rasha Mohamed Mostafa Haggag | Keywords | Impact of molecular prognostic factors in advanced bladder cancer patients receiving chemotherapy | Issue Date | 2009 | Description | Background: Bladder carcinoma is the foremost oncological problem in Egypt, being the most common malignant tumor among Egyptian males. Gemcitabine is an active agent in the treatment of bladder cancer. Prolonged infusion of gemcitabine and cisplatin is a |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 93994r1870.pdf | 242.75 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.